Hookipa Pharma Inc

$11.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.27%) Today

$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell HOOK and other stocks, options, and ETFs commission-free!

About HOOK

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its product includes VaxWace and TheraT. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, Katherine Cohen, and Daniel Pinschewer in 2011 and is headquartered in New York, NY. The listed name for HOOK is HOOKIPA Pharma Inc. Common Stock.

CEO

Jörn Aldag

Employees

104

Headquarters

New York, New York

Founded

2011

Market Cap

284.17M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

40.70K

High Today

$11.59

Low Today

$11.06

Open Price

$11.06

Volume

28.67K

52 Week High

$14.37

52 Week Low

$5.80

Collections

HOOK Earnings

-$9.27

-$6.18

-$3.09

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 18, Pre-Market